Detection of a complex that associates with the Bβ fibrinogen G-455-A polymorphism

被引:49
作者
Brown, ET
Fuller, GM
机构
[1] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA
[2] Univ Alabama, Med Genet Lab, Birmingham, AL 35294 USA
关键词
D O I
10.1182/blood.V92.9.3286.421k20_3286_3293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The promoter region of the B beta fibrinogen gene containing the polymorphic site (G(-455)-A) shows an increase in fibrinogen levels for individuals containing an adenine rather than a guanine. Two methods were used to explore the possible functional role of this region, Electrophoretic mobility shift assays (EMSAs) were performed using specific DNA probes containing base sequences pertinent to the allelic site. Specific DNA binding proteins were detected and their binding characteristics were determined, Secondly, we placed DNA fragments containing different -455 nucleotide substitutions of the B beta promoter upstream of a luciferase reporter gene and transfected them into HepG2 cells to determine their effect on transactivation, An adenine at position -455 resulted in greater luciferase activity than when a guanine was present, UV cross-linking bound protein to the DNA demonstrated a 47-kD protein binding preferentially to the site when a guanine rather than an adenine was present at -455, We hypothesize that a transactivation protein complex associates with the site, but its association is stronger when guanine is present, thereby slowing downstream B beta gene transcription, These data provide the first molecular evidence that accounts for the increase in fibrinogen in individuals carrying this allele. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:3286 / 3293
页数:8
相关论文
共 48 条
[1]  
ANDERSON GM, 1993, J BIOL CHEM, V268, P22650
[2]  
Ausubel FA, 1995, CURRENT PROTOCOLS MO
[3]   THE ACUTE-PHASE RESPONSE [J].
BAUMANN, H ;
GAULDIE, J .
IMMUNOLOGY TODAY, 1994, 15 (02) :74-80
[4]  
BAUMANN RE, 1994, HUM GENET, V94, P165
[5]   beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction - The ECTIM study [J].
Behague, I ;
Poirier, O ;
Nicaud, V ;
Evans, A ;
Arveiler, D ;
Luc, G ;
Cambou, JP ;
Scarabin, PY ;
Bara, L ;
Green, F ;
Cambien, F .
CIRCULATION, 1996, 93 (03) :440-449
[6]   FIBRINOGEN, FACTOR-VII CLOTTING ACTIVITY AND CORONARY-ARTERY DISEASE SEVERITY [J].
BROADHURST, P ;
KELLEHER, C ;
HUGHES, L ;
IMESON, JD ;
RAFTERY, EB .
ATHEROSCLEROSIS, 1990, 85 (2-3) :169-173
[7]  
Crabtree G.R., 1987, MOL BASIS BLOOD DIS, P631
[8]   THE HUMAN BETA-FIBRINOGEN PROMOTER CONTAINS A HEPATOCYTE NUCLEAR FACTOR 1-DEPENDENT INTERLEUKIN-6-RESPONSIVE ELEMENT [J].
DALMON, J ;
LAURENT, M ;
COURTOIS, G .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (02) :1183-1193
[9]  
DANG CV, 1989, AM J MED, V87, P567
[10]   GENDER-RELATED ASSOCIATION BETWEEN BETA-FIBRINOGEN GENOTYPE AND PLASMA-FIBRINOGEN LEVELS AND LINKAGE DISEQUILIBRIUM AT THE FIBRINOGEN LOCUS IN GREENLAND INUIT [J].
DEMAAT, MPM ;
DEKNIJFF, P ;
GREEN, FR ;
THOMAS, AE ;
JESPERSEN, J ;
KLUFT, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (07) :856-860